Janux Therapeutics Inc (JANX)
55.80
+1.41
(+2.59%)
USD |
NASDAQ |
Nov 04, 16:00
56.00
+0.20
(+0.36%)
After-Hours: 20:00
Janux Therapeutics Total Assets (Quarterly): 691.41M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 691.41M |
| March 31, 2024 | 688.98M |
| December 31, 2023 | 380.41M |
| September 30, 2023 | 386.85M |
| June 30, 2023 | 341.50M |
| March 31, 2023 | 352.96M |
| December 31, 2022 | 364.01M |
| September 30, 2022 | 375.76M |
| Date | Value |
|---|---|
| June 30, 2022 | 385.36M |
| March 31, 2022 | 368.60M |
| December 31, 2021 | 379.82M |
| September 30, 2021 | 391.08M |
| June 30, 2021 | 396.82M |
| March 31, 2021 | 71.82M |
| December 31, 2020 | 16.22M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
16.22M
Minimum
Dec 2020
691.41M
Maximum
Jun 2024
372.77M
Average
379.82M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Dynavax Technologies Corp | 1.016B |
| Krystal Biotech Inc | 917.66M |
| Arcus Biosciences Inc | 1.186B |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 33.74M |
| Shareholders Equity (Quarterly) | 657.68M |
| Current Ratio | 57.34 |